ALGS - CIK 0001799448
Aligos Therapeutics, Inc. has filed 334 documents with the SEC between 2020 and 2026. The most frequent type is insider trade (98 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-05-15 | 2024-05-09 |
| Major company event | 8-K | 2024-05-07 | 2024-05-07 |
| Quarterly report | 10-Q | 2024-05-07 | 2024-03-31 |
| Annual report to shareholders | ARS | 2024-04-29 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-29 | - |
| Proxy statement | DEF 14A | 2024-04-29 | 2024-06-27 |
| PRE 14A | - | 2024-04-16 | 2024-06-27 |
| Employee stock plan | S-8 | 2024-03-12 | - |
| Major company event | 8-K | 2024-03-12 | 2024-03-12 |
| Annual report | 10-K | 2024-03-12 | 2023-12-31 |
| Insider trade | 4 | 2024-03-04 | 2024-03-01 |
| Insider trade | 4 | 2024-03-04 | 2024-03-01 |
| Insider trade | 4 | 2024-03-04 | 2024-03-01 |
| Insider trade | 4 | 2024-03-04 | 2024-03-01 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Insider trade | 4 | 2024-02-28 | 2024-02-27 |
| Major company event | 8-K | 2024-02-28 | 2024-02-27 |
| SC TO-I/A | - | 2024-02-28 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake | SC 13G | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Activist ownership stake (update) | SC 13D/A | 2024-02-08 | - |
| SC TO-I | - | 2024-01-30 | - |
| SC TO-C | - | 2024-01-25 | - |
| Major company event | 8-K | 2024-01-25 | 2024-01-25 |
| 424B3 | - | 2023-11-28 | - |
| EFFECT | - | 2023-11-27 | - |
| Company correspondence | CORRESP | 2023-11-22 | - |
| Major company event | 8-K | 2023-11-22 | 2023-11-20 |
| SEC correspondence | UPLOAD | 2023-11-21 | - |
| Securities registration | S-3 | 2023-11-17 | - |
| Major company event | 8-K | 2023-11-15 | 2023-11-09 |
| D | - | 2023-11-07 | - |
| Passive ownership stake (update) | SC 13G/A | 2023-11-07 | - |
| New insider ownership | 3 | 2023-11-07 | 2023-10-25 |
| Activist ownership stake | SC 13D | 2023-11-06 | - |
| Passive ownership stake | SC 13G | 2023-11-02 | - |
| Major company event | 8-K | 2023-11-02 | 2023-11-02 |
| Quarterly report | 10-Q | 2023-11-02 | 2023-09-30 |
| Insider trade | 4 | 2023-10-27 | 2023-10-25 |